Article by: Radhi Shah, Lizzie Fanckboner, and Tom Zuber Exciting developments are underway in the Golden State, as California inches closer to legalizing certain psychedelics for individuals aged 21 and older. The bill (SB 58) has successfully passed through the California Senate, awaiting the final signature of Governor Gavin Newsom to become law. If approved,…
Article by: Partner Jeff Zuber, Counsel Raza Lawrence, and Associate Lizzie Fanckboner. In response to the COVID-19 public health emergency (PHE) declared by the United States Secretary of Health and Human Services, the Drug Enforcement Administration (DEA) adopted a new set of policies to allow DEA-registered practitioners to prescribe controlled substances without having to interact in person…
Article by: Partner Jeff Zuber, Counsel Raza Lawrence, and Associate Lizzie Fanckboner. Advisory Board Appointed Colorado voters passed Proposition 122, the Natural Medicine Health Act (NMHA), in November 2022. Now codified in the Colorado Revised Statutes, the NMHA is in a development phase, where the newly appointed Natural Medicine Advisory Board, once confirmed, will work to draft…
Article by: Partner Jeff Zuber, Counsel Raza Lawrence, and Associate Lizzie Fanckboner. Psilocybin, the active ingredient in magic mushrooms, has been the subject of increasing scientific research in recent years. Its potential therapeutic benefits for a variety of mental health conditions, such as depression and anxiety, have led to a growing movement to legalize and regulate its…
Article by: Partner Jeff Zuber, Counsel Raza Lawrence, and Associate Lizzie Fanckboner. In November 2022, Colorado voters passed Proposition 122, the Natural Medicine Health Act (NMHA), which establishes a regulated natural medicine access program and provisions for personal use of natural medicines. Under this new law, Colorado will become the second US state – following Oregon –…
Article by: Partner Jeff Zuber, Counsel Raza Lawrence, and Associate Lizzie Fanckboner. On January 2, 2023, Oregon began accepting applications for its first-in-the nation regulated psilocybin services program. Under the new regulatory program, licensed psilocybin manufacturers will be permitted to manufacture and distribute psilocybin and psilocybin-based edible products, for use by anyone at least 21 years old…
Article by: Partner Jeff Zuber, Counsel Raza Lawrence, and Associate Lizzie Fanckboner. We are quickly approaching a significant milestone in the history of the American psychedelics industry. On January 2, 2023, Oregon will be the first state in the nation to accept licensing applications from applicants seeking to participate in its commercial psilocybin industry — a…
Article by: Partner Jeff Zuber, Counsel Raza Lawrence, Associate Lizzie Fanckboner, and Associate Terron East. The Oregon Health Authority released the long-awaited draft rules for its Psilocybin Services Program on September 1st. The draft rules lay out a proposed framework for the first commercial psilocybin licensing program in the nation, and are an exciting step toward…
By: Associate Lizzie Fanckboner In 2019, Denver passed Ordinance 301, making it the first city in the US to decriminalize psilocybin-containing mushrooms. While the ordinance did not legalize psilocybin, it set out to “deprioritize, to the greatest extent possible” criminal penalties imposed by the City and County of Denver “for the personal use and personal…
By Tom Zuber and Radhi Shah The State of California took a step closer to decriminalizing possession of psychedelic drugs as the senate passed a bill SB 519, 21-16 on a floor vote. The bill, sponsored by Sen. Scott Wiener, cleared three separate committees. The State Department of Public Health would be required to establish…